These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Structural Basis for Inhibition of Human Autotaxin by Four Potent Compounds with Distinct Modes of Binding. Stein AJ; Bain G; Prodanovich P; Santini AM; Darlington J; Stelzer NM; Sidhu RS; Schaub J; Goulet L; Lonergan D; Calderon I; Evans JF; Hutchinson JH Mol Pharmacol; 2015 Dec; 88(6):982-92. PubMed ID: 26371182 [TBL] [Abstract][Full Text] [Related]
48. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis. Orosa B; García S; Conde C Eur J Pharmacol; 2015 Oct; 765():228-33. PubMed ID: 26297977 [TBL] [Abstract][Full Text] [Related]
49. MicroRNA Regulation of the Autotaxin-Lysophosphatidic Acid Signaling Axis. Murph MM Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540086 [TBL] [Abstract][Full Text] [Related]
50. Autotaxin exacerbates tumor progression by enhancing MEK1 and overriding the function of miR-489-3p. Kuppa SS; Jia W; Liu S; Nguyen H; Smyth SS; Mills GB; Dobbin KK; Hardman WJ; Murph MM Cancer Lett; 2018 Sep; 432():84-92. PubMed ID: 29859298 [TBL] [Abstract][Full Text] [Related]
51. Discovery of BI-2545: A Novel Autotaxin Inhibitor That Significantly Reduces LPA Levels in Vivo. Kuttruff CA; Ferrara M; Bretschneider T; Hoerer S; Handschuh S; Nosse B; Romig H; Nicklin P; Roth GJ ACS Med Chem Lett; 2017 Dec; 8(12):1252-1257. PubMed ID: 29259743 [TBL] [Abstract][Full Text] [Related]
52. Synthesis of novel 2-pyrrolidinone and pyrrolidine derivatives and study of their inhibitory activity against autotaxin enzyme. Gerokonstantis DT; Nikolaou A; Magkrioti C; Afantitis A; Aidinis V; Kokotos G; Moutevelis-Minakakis P Bioorg Med Chem; 2020 Jan; 28(2):115216. PubMed ID: 31864778 [TBL] [Abstract][Full Text] [Related]